You are here

  • Home
  • Archive
  • Volume 16, Issue 3
  • De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy

Article info

Article menu
Download PDFPDF
Case Reports: Unusual association of diseases/symptoms
De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy

Authors

  1. Correspondence to Dr Anil Ananthaneni; aan005{at}lsuhs.edu
View Full Text

Citation

Ananthaneni A, Benzar T, Hafiz N, et al
De novo monocytic-M5b AML with t(8;16) (p11.2; p13.3) KAT6A/CREBBP fusion and FLT3-TKD mutation complicated by chemotherapy-induced Takotsubo cardiomyopathy
BMJ Case Reports CP 2023;16:e253812.

Publication history

  • Accepted March 20, 2023
  • First published March 28, 2023.
Online issue publication 
January 24, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.